Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample

Journal of Infection

Volumn 69, Issue 5, 2014, Pages 507-515

  Clark, Tristan W ^a,b   Medina, Marie Jo ^b   Batham, Sally ^b   Curran, Martin D ^c   Parmar, Surendra ^c   Nicholson, Karl G ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Acute respiratory illness; Adults; Antibiotics; Hospitalisation; Respiratory viruses

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BACTERIUM DETECTION; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DRUG MISUSE; ENTEROVIRUS; FEMALE; FLU LIKE SYNDROME; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDY; RHINOVIRUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; ACUTE DISEASE; BACTERIAL INFECTIONS; BACTERIUM; COMMUNITY-ACQUIRED INFECTIONS; DISEASE COURSE; DRUG UTILIZATION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; RESPIRATORY TRACT INFECTIONS; VIROLOGY; VIRUS; VIRUS DISEASES;

ACUTE DISEASE; ADULT; AGED; ANTI-BACTERIAL AGENTS; ASTHMA; BACTERIA; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE PROGRESSION; DRUG UTILIZATION; FEMALE; GREAT BRITAIN; HOSPITALIZATION; HUMANS; MALE; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; VIRUSES;

EID: 84908554057     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.07.023     Document Type: Article

References (40)

1. Department of Health hospital episode statistics 1998-2008 NHS HES online 2009, Available at:. http://www.hesonline.nhs.uk.
2. Mansbach J.M., McAdam A.J., Clark S., Hain P.D., Flood R.G., Acholonu U., et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 2008, 15(2):111-118.
3. Juvén T., Mertsola J., Waris M., Leinonen M., Meurman O., Roivainen M., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000, 19(4):293-298.
4. Papadopoulos N.G., Christodoulou I., Rohde G., Agache I., Almqvist C., Bruno A., et al. Viruses and bacteria in acute asthma exacerbations - A GA2LEN-DARE* systematic review. Allergy 2011, 66:458-468.
5. Mohan A., Chandra S., Agarwal D., Guleria R., Broor S., Gaur B., et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 2010, 15(3):536-542.
6. Jennings L.C., Anderson T.P., Beynon K.A., Chua A., Laing R.T., Werno A.M., et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008, 63(1):42-48.
7. Johansson N., Kalin M., Tiveljung-Lindell A., Giske C.G., Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010, 50(2):202-209.
8. Templeton K.E., Scheltinga S.A., van den Eeden W.C., Graffelman A.W., van den Broek P.J., Claas E.C. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005, 41(3):345-351.
9. Johnstone J., Majumdar S.R., Fox J.D., Marrie T.J. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008, 134(6):1141-1148.
10. Lieberman D., Shimoni A., Shemer-Avni Y., Keren-Naos A., Shtainberg R., Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010, 138(4):811-816.
11. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352(17):1749-1759.
12. Widmer K., Zhu Y., Williams J.V., Griffin M.R., Edwards K.M., Talbot H.K. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012, 206(1):56-62.
13. Falsey A.R., Becker K.L., Swinburne A.J., Nylen E.S., Formica M.A., Hennessey P.A., et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 2013, 208(3):432-441.
14. Fridkin S., Baggs J., Fagan R., Magill S., Pollack L.A., Malpiedi P., et al. Centers for Disease Control and Prevention (CDC). Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014, 63(9):194-200.
15. Smith S.M., Fahey T., Smucny J., Becker L.A. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014, 3:CD000245.
16. Graham V.A., Milton A.F., Knowles G.K., Davies R.J. Routine antibiotics in hospital management of acute asthma. Lancet 1982, 1(8269):418-420.
17. Ram F.S., Rodriguez-Roisin R., Granados-Navarrete A., Garcia-Aymerich J., Barnes N.C. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, (2)(2):CD004403.
18. National Clinical Guideline Centre Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care 2010, National Clinical Guideline Centre, London, Available from:. http://guidance.nice.org.uk/CG101/Guidance/pdf/English.
19. Hawkey P.M., Jones A.M. The changing epidemiology of resistance. J Antimicrob Chemother 2009, 64(Suppl 1):i3-10.
20. Steinman M.A., Gonzales R., Linder J.A., Landefeld C.S. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003, 138(7):525-533.
21. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44(2):159-177.
22. Bramer G.R. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 1988, 41(1):32-36.
23. Ellis J.S., Curran M.D. Simultaneous molecular detection and confirmation of influenza A H5, with internal control. Diagnostic virology protocols (Methods in Molecular Biology series) 2011, 665:161-181. Humana Press. 2nd ed.
24. Nicholson K.G., Kent J., Hammersley V., Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997, 315(7115):1060-1064.
25. Krüger S., Ewig S., Papassotiriou J., Kunde J., Marre R., von Baum H., et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respir Res 2009, 10:65. CAPNETZ Study Group.
26. Ingram P.R., Inglis T., Moxon D., Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010, 36(3):528-532.
27. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. Pneumonia guidelines committee of the BTS standards of care committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3). iii1-55.
28. Houck P.M., Bratzler D.W., Nsa W., Ma A., Bartlett J.G. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004, 164(6):637-644.
29. Cesario T.C. Viruses associated with pneumonia in adults. Clin Infect Dis 2012, 55(1):107-113.
30. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006, 6:303-312.
31. Stolz D., Christ-Crain M., Bingisser R., Leuppi J., Miedinger D., Müller C., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007, 131(1):9-19.
32. Nguyen-Van-Tam J.S., Openshaw P.J., Hashim A., Gadd E.M., Lim W.S., Semple M.G., et al. Influenza Clinical Information Network (FLU-CIN). Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave. Thorax 2009, 2010(65):645-651.
33. Sutherland E.R., King T.S., Icitovic N., Ameredes B.T., Bleecker E., Boushey H.A., et al. National Heart, Lung and Blood Institute's Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010, 126(4):747-753.
34. British Thoracic Society Scottish Intercollegiate Guidelines Network BTS guidelines: British guideline on the management of Asthma. Thorax 2008, 63:iv1-iv121.
35. Gonzales R., Sande M.A. Uncomplicated acute bronchitis. Ann Intern Med 2000, 133(12):981-991.
36. Hombrouck A., Sabbe M., Van Casteren V., Wuillaume F., Hue D., Reynders M., et al. Viral aetiology of influenza-like illness in Belgium during the influenza A(H1N1)2009 pandemic. Eur J Clin Microbiol Infect Dis 2012, 31(6):999-1007.
37. Thiberville S.D., Ninove L., Vu Hai V., Botelho-Nevers E., Gazin C., Thirion L., et al. The viral etiology of an influenza-like illness during the 2009 pandemic. J Med Virol 2012, 84(7):1071-1079.
38. Little P., Stuart B., Moore M., Coenen S., Butler C.C., Godycki-Cwirko M., et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013, 13(2):123-129.
39. National Institute for Health and Clinical Excellence Amantadine, oseltamivir, and zanamivir for the treatment of influenza London: NICE 2009.
40. Muthuri S.G., Myles P.R., Venkatesan S., Leonardi-Bee J., Nguyen-Van-Tam J.S. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013, 207(4):553-563.